In this study, intracerebroventricular HP-β-CD treatment showed attenuating effects on NPC-related neuronal and liver injury and effects of reducing cerebellar, hepatic, and serum levels of GPNMB in Npc1−/− mice. Here, NPC1 is linked to nasopharyngeal carcinoma.